What does Fennec Pharmaceuticals Inc. do?
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric…
What is Fennec Pharmaceuticals Inc.'s P/E and P/B ratio?
Fennec Pharmaceuticals Inc. has a P/E ratio of -86.0 and a P/B ratio of 8.53.
What is Fennec Pharmaceuticals Inc.'s debt-to-equity ratio?
Fennec Pharmaceuticals Inc. has a debt-to-equity ratio of 0.00.
How much does Fennec Pharmaceuticals Inc. owe compared with what it owns?
Fennec Pharmaceuticals Inc. owes $0.44 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Fennec Pharmaceuticals Inc.'s Positivity rank?
Fennec Pharmaceuticals Inc. is ranked #5,672 of 6,774 companies globally and #3,131 of 4,000 in United States on PositoAI, with a Positivity Score of 16,323.
Does Fennec Pharmaceuticals Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Fennec Pharmaceuticals Inc..
Where can I read the latest news about Fennec Pharmaceuticals Inc.?
Recent headlines about Fennec Pharmaceuticals Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Fennec Pharmaceuticals Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Fennec Pharmaceuticals Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.